Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The application of GM-CSF in febrile neutropenia did not result in a significant shortening of the hospitalisation period, nor of the time to resolution of fever, despite a faster recovery of neutrophils for the whole group of patients.